Omgeo has partnered up with portfolio management solutions provider, Enfusion, to offer clients a new solution that increases middle-office efficiencies for hedge funds across asset classes.
The solution connects Enfusion’s platform Integráta with Omgeo central trade manager (Omgeo CTM)—a strategic platform for the central matching of domestic and cross-border exchange-traded derivatives (ETDs), contracts for difference, equities and fixed income transactions.
The joint offering automates ETD post-trade processes for the global hedge fund industry for the global hedge fund industry, enabling clients to access the central matching benefits of Omgeo CTM directly from their Integráta portfolio management interface.
Users will be able to standardise post-trade workflows and enhance straight through processing of ETD trades, which in turn will increase accuracy and efficiency while reducing costs and operational risks.
Tarek Hammond, managing partner at Enfusion, said: “Our clients are moving toward more integrated workflows in post-trade operations, and many continue to express an interest in this new solution. Partnering with Omgeo is a logical step as it allows us to assist our clients to increase efficiencies in the processing of listed derivatives and reduce operational risks.”
Ted Leveroni, executive director of derivative strategy and external relations at Omgeo, added: “As hedge funds continue to boost their trading strategies with listed derivatives, they need to ensure their middle- and back-office processes keep pace with their front-office activities. This new joint offering highlights Omgeo’s aim to facilitate efficiency across the evolving global markets, increasing the use of best practice automation and lowering risk for buy- and sell-side firms alike.”
